Your browser doesn't support javascript.
loading
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC.
Welsh, James W; Heymach, John V; Guo, Chunxiao; Menon, Hari; Klein, Katherine; Cushman, Taylor R; Verma, Vivek; Hess, Kenneth R; Shroff, Girish; Tang, Chad; Skoulidis, Ferdinandos; Jeter, Melenda; Comeaux, Nathan; Patel, Roshal R; Chen, Dawei; Ozgen, Tugce; Nguyen, Quynh-Nhu; Chang, Joe Y; Altan, Mehmet; Zhang, Jianjun; Papadimitrakopoulou, Vassiliki A; Simon, George R; Byers, Lauren A; Glisson, Bonnie.
Afiliación
  • Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: jwelsh@mdanderson.org.
  • Heymach JV; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Guo C; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Menon H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Klein K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cushman TR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Verma V; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hess KR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shroff G; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Skoulidis F; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jeter M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Comeaux N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel RR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ozgen T; Department of Radiation Oncology, Ankara University School of Medicine, Ankara, Turkey.
  • Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang JY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Altan M; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Papadimitrakopoulou VA; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Simon GR; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Byers LA; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Glisson B; Department of Thoracic Head & Neck Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
J Thorac Oncol ; 15(12): 1919-1927, 2020 12.
Article en En | MEDLINE | ID: mdl-32916308

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article